Related Experiment Video
Updated: Nov 11, 2025

04:16
Platelet-Derived Extracellular Vesicle Functionalization of Ti Implants
Published on: August 5, 2021
2.5K
ON or OFF: Triggered therapies from anodized nano-engineered titanium implants.
Anjana Jayasree1, Sašo Ivanovski1, Karan Gulati1
1The University of Queensland, School of Dentistry, Herston, QLD 4006, Australia.
Summary
Surface modification of titanium implants using TiO2 nanotubes can be triggered for responsive therapies. This review explores triggers for enhanced osseointegration and antibacterial effects, addressing clinical translation challenges.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Orthopedic Surgery
Background:
- Titanium (Ti) implants are crucial for bone repair, with surface modifications enhancing osseointegration and providing antibacterial properties.
- TiO2 nanotubes (TNTs) fabricated on Ti implants show promise for improved implant performance.
- Current TNT systems lack the ability to modulate therapeutic release in response to the local bone microenvironment post-implantation.
Purpose of the Study:
- To review and evaluate triggered therapeutic delivery systems for modified Ti implants, focusing on TNTs.
- To explore various triggers (biological, electrical, magnetic, electromagnetic) for responsive therapies.
- To assess cytotoxicity and identify challenges for clinical translation.
Main Methods:
- Literature review of research on triggered therapies from modified Ti implants, with emphasis on TNTs.
- Critical evaluation of biological, electrical, magnetic, and electromagnetic triggers.
- Analysis of cytotoxicity data and clinical translation hurdles.
Main Results:
- Various triggers can activate and tune therapies from TNT-modified Ti implants in situ.
- Responsive therapies offer potential for maximal therapeutic effect by adapting to local conditions.
- Cytotoxicity and specific research challenges require further investigation for clinical application.
Conclusions:
- Triggered therapies from modified Ti implants, particularly TNTs, represent a paradigm shift in implantology.
- Further research is needed to overcome cytotoxicity concerns and address challenges for successful clinical translation.
- Responsive implant systems hold significant potential for improved patient outcomes in orthopedic and dental applications.

